US Stock MarketDetailed Quotes

BSX Boston Scientific

Watchlist
  • 102.060
  • +1.340+1.33%
Trading Feb 26 12:42 ET
150.62BMarket Cap81.65P/E (TTM)

Boston Scientific Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
17.61%16.75B
22.44%4.56B
19.34%4.21B
14.48%4.12B
13.78%3.86B
12.29%14.24B
14.90%3.73B
11.26%3.53B
10.94%3.6B
12.00%3.39B
Operating revenue
17.61%16.75B
22.44%4.56B
19.34%4.21B
14.48%4.12B
13.78%3.86B
12.29%14.24B
14.90%3.73B
11.26%3.53B
10.94%3.6B
12.00%3.39B
Cost of revenue
20.99%5.26B
27.81%1.47B
19.16%1.31B
20.04%1.27B
16.25%1.21B
9.83%4.35B
13.45%1.15B
12.46%1.1B
3.52%1.06B
8.90%1.04B
Gross profit
16.11%11.49B
20.01%3.1B
19.41%2.9B
12.12%2.85B
12.69%2.65B
13.40%9.9B
15.55%2.58B
10.73%2.43B
14.40%2.54B
13.42%2.35B
Operating expense
13.51%8.49B
17.54%2.31B
19.92%2.18B
5.99%2.05B
10.65%1.95B
11.73%7.48B
15.01%1.96B
7.90%1.82B
13.56%1.94B
11.14%1.77B
Selling and administrative expenses
15.30%5.98B
16.90%1.61B
25.76%1.56B
6.79%1.45B
12.26%1.36B
14.82%5.19B
18.57%1.38B
9.72%1.24B
16.22%1.35B
14.62%1.22B
Research and development costs
14.21%1.62B
26.45%459M
14.33%407M
6.69%383M
8.61%366M
6.88%1.41B
10.00%363M
5.01%356M
7.16%359M
5.64%337M
Depreciation amortization depletion
3.38%856M
8.17%225M
-1.44%205M
1.43%213M
5.42%214M
3.11%828M
4.52%208M
2.97%208M
2.94%210M
2.53%203M
-Depreciation and amortization
3.38%856M
8.17%225M
-1.44%205M
1.43%213M
5.42%214M
3.11%828M
4.52%208M
2.97%208M
2.94%210M
2.53%203M
Other operating expenses
-28.26%33M
-18.18%9M
-54.55%5M
-25.00%9M
-9.09%10M
-2.13%46M
-15.38%11M
0.00%11M
--12M
-8.33%11M
Operating profit
24.15%3B
27.83%790M
17.90%718M
31.63%799M
18.87%693M
18.88%2.42B
17.27%618M
20.12%609M
17.18%607M
20.95%583M
Net non-operating interest income expense
18.52%-198M
162.79%27M
-19.70%-79M
-10.00%-77M
-6.15%-69M
47.17%-243M
20.37%-43M
-4.76%-66M
-9.38%-70M
76.70%-65M
Non-operating interest income
386.36%107M
----
----
----
----
120.00%22M
----
----
----
----
Non-operating interest expense
15.09%305M
23.08%80M
19.70%79M
10.00%77M
6.15%69M
-43.62%265M
1.56%65M
4.76%66M
9.38%70M
-76.70%65M
Other net income (expense)
-177.13%-521M
-233.33%-230M
-56.72%29M
-174.55%-302M
76.00%-18M
56.68%-188M
11.54%-69M
133.50%67M
0.00%-110M
-59.57%-75M
Gain on sale of security
5.00%-95M
----
----
----
----
-212.50%-100M
----
----
----
----
Special income (charges)
-436.49%-397M
-242.42%-113M
-82.35%15M
-203.26%-279M
37.50%-20M
80.83%-74M
73.81%-33M
157.05%85M
4.17%-92M
-100.00%-32M
-Less:Restructuring and merger&acquisition
-91.34%11M
-90.91%3M
-155.56%-15M
-91.43%3M
-37.50%20M
115.25%127M
222.22%33M
12.50%27M
-25.53%35M
100.00%32M
-Less:Impairment of capital assets
565.52%386M
--110M
--0
384.21%276M
----
-56.06%58M
--0
-100.80%-1M
714.29%57M
----
-Less:Other special charges
----
----
----
----
----
-164.16%-111M
--0
---111M
----
----
-Gain on sale of business
--0
----
----
----
----
--0
----
----
----
----
Other non- operating income (expenses)
-107.14%-29M
-134.38%-22M
177.78%14M
-27.78%-23M
104.65%2M
12.50%-14M
-20.00%64M
64.71%-18M
-28.57%-18M
-38.71%-43M
Income before tax
14.96%2.28B
15.84%585M
9.67%669M
-1.41%420M
36.94%608M
73.97%1.99B
27.53%505M
148.98%610M
23.48%426M
184.62%444M
Income tax
10.94%436M
2,200.00%23M
90.48%200M
-37.18%98M
-12.21%115M
-11.29%393M
-99.61%1M
84.21%105M
83.53%156M
191.11%131M
Net income
15.95%1.85B
11.51%562M
-7.14%468M
19.26%322M
57.01%493M
128.08%1.59B
260.00%504M
168.09%504M
3.85%270M
185.45%314M
Net income continuous Operations
15.95%1.85B
11.51%562M
-7.13%469M
19.26%322M
57.51%493M
128.08%1.59B
257.45%504M
168.62%505M
3.85%270M
181.98%313M
Minority interest income
-700.00%-8M
-300.00%-4M
0
-2M
1M
-1M
-1M
0
0
0
Net income attributable to the parent company
16.38%1.85B
12.08%566M
-7.14%468M
20.00%324M
56.69%492M
128.22%1.59B
260.71%505M
168.09%504M
3.85%270M
185.45%314M
Preferred stock dividends
-58.18%23M
0
-35.71%9M
0.00%14M
Other preferred stock dividends
Net income attributable to common stockholders
18.03%1.85B
11.88%565M
-7.13%469M
24.14%324M
65.00%495M
144.55%1.57B
300.79%505M
190.23%505M
6.10%261M
209.28%300M
Basic earnings per share
16.67%1.26
11.76%0.38
-5.88%0.32
22.22%0.22
61.90%0.34
140.00%1.08
277.78%0.34
183.33%0.34
5.88%0.18
200.00%0.21
Diluted earnings per share
16.82%1.25
11.76%0.38
-5.88%0.32
22.22%0.22
57.14%0.33
137.78%1.07
277.78%0.34
183.33%0.34
5.88%0.18
200.00%0.21
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 17.61%16.75B22.44%4.56B19.34%4.21B14.48%4.12B13.78%3.86B12.29%14.24B14.90%3.73B11.26%3.53B10.94%3.6B12.00%3.39B
Operating revenue 17.61%16.75B22.44%4.56B19.34%4.21B14.48%4.12B13.78%3.86B12.29%14.24B14.90%3.73B11.26%3.53B10.94%3.6B12.00%3.39B
Cost of revenue 20.99%5.26B27.81%1.47B19.16%1.31B20.04%1.27B16.25%1.21B9.83%4.35B13.45%1.15B12.46%1.1B3.52%1.06B8.90%1.04B
Gross profit 16.11%11.49B20.01%3.1B19.41%2.9B12.12%2.85B12.69%2.65B13.40%9.9B15.55%2.58B10.73%2.43B14.40%2.54B13.42%2.35B
Operating expense 13.51%8.49B17.54%2.31B19.92%2.18B5.99%2.05B10.65%1.95B11.73%7.48B15.01%1.96B7.90%1.82B13.56%1.94B11.14%1.77B
Selling and administrative expenses 15.30%5.98B16.90%1.61B25.76%1.56B6.79%1.45B12.26%1.36B14.82%5.19B18.57%1.38B9.72%1.24B16.22%1.35B14.62%1.22B
Research and development costs 14.21%1.62B26.45%459M14.33%407M6.69%383M8.61%366M6.88%1.41B10.00%363M5.01%356M7.16%359M5.64%337M
Depreciation amortization depletion 3.38%856M8.17%225M-1.44%205M1.43%213M5.42%214M3.11%828M4.52%208M2.97%208M2.94%210M2.53%203M
-Depreciation and amortization 3.38%856M8.17%225M-1.44%205M1.43%213M5.42%214M3.11%828M4.52%208M2.97%208M2.94%210M2.53%203M
Other operating expenses -28.26%33M-18.18%9M-54.55%5M-25.00%9M-9.09%10M-2.13%46M-15.38%11M0.00%11M--12M-8.33%11M
Operating profit 24.15%3B27.83%790M17.90%718M31.63%799M18.87%693M18.88%2.42B17.27%618M20.12%609M17.18%607M20.95%583M
Net non-operating interest income expense 18.52%-198M162.79%27M-19.70%-79M-10.00%-77M-6.15%-69M47.17%-243M20.37%-43M-4.76%-66M-9.38%-70M76.70%-65M
Non-operating interest income 386.36%107M----------------120.00%22M----------------
Non-operating interest expense 15.09%305M23.08%80M19.70%79M10.00%77M6.15%69M-43.62%265M1.56%65M4.76%66M9.38%70M-76.70%65M
Other net income (expense) -177.13%-521M-233.33%-230M-56.72%29M-174.55%-302M76.00%-18M56.68%-188M11.54%-69M133.50%67M0.00%-110M-59.57%-75M
Gain on sale of security 5.00%-95M-----------------212.50%-100M----------------
Special income (charges) -436.49%-397M-242.42%-113M-82.35%15M-203.26%-279M37.50%-20M80.83%-74M73.81%-33M157.05%85M4.17%-92M-100.00%-32M
-Less:Restructuring and merger&acquisition -91.34%11M-90.91%3M-155.56%-15M-91.43%3M-37.50%20M115.25%127M222.22%33M12.50%27M-25.53%35M100.00%32M
-Less:Impairment of capital assets 565.52%386M--110M--0384.21%276M-----56.06%58M--0-100.80%-1M714.29%57M----
-Less:Other special charges ---------------------164.16%-111M--0---111M--------
-Gain on sale of business --0------------------0----------------
Other non- operating income (expenses) -107.14%-29M-134.38%-22M177.78%14M-27.78%-23M104.65%2M12.50%-14M-20.00%64M64.71%-18M-28.57%-18M-38.71%-43M
Income before tax 14.96%2.28B15.84%585M9.67%669M-1.41%420M36.94%608M73.97%1.99B27.53%505M148.98%610M23.48%426M184.62%444M
Income tax 10.94%436M2,200.00%23M90.48%200M-37.18%98M-12.21%115M-11.29%393M-99.61%1M84.21%105M83.53%156M191.11%131M
Net income 15.95%1.85B11.51%562M-7.14%468M19.26%322M57.01%493M128.08%1.59B260.00%504M168.09%504M3.85%270M185.45%314M
Net income continuous Operations 15.95%1.85B11.51%562M-7.13%469M19.26%322M57.51%493M128.08%1.59B257.45%504M168.62%505M3.85%270M181.98%313M
Minority interest income -700.00%-8M-300.00%-4M0-2M1M-1M-1M000
Net income attributable to the parent company 16.38%1.85B12.08%566M-7.14%468M20.00%324M56.69%492M128.22%1.59B260.71%505M168.09%504M3.85%270M185.45%314M
Preferred stock dividends -58.18%23M0-35.71%9M0.00%14M
Other preferred stock dividends
Net income attributable to common stockholders 18.03%1.85B11.88%565M-7.13%469M24.14%324M65.00%495M144.55%1.57B300.79%505M190.23%505M6.10%261M209.28%300M
Basic earnings per share 16.67%1.2611.76%0.38-5.88%0.3222.22%0.2261.90%0.34140.00%1.08277.78%0.34183.33%0.345.88%0.18200.00%0.21
Diluted earnings per share 16.82%1.2511.76%0.38-5.88%0.3222.22%0.2257.14%0.33137.78%1.07277.78%0.34183.33%0.345.88%0.18200.00%0.21
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.